GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vivanza Biosciences Ltd (BOM:530057) » Definitions » Days Sales Outstanding

Vivanza Biosciences (BOM:530057) Days Sales Outstanding : 407.43 (As of Sep. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Vivanza Biosciences Days Sales Outstanding?

Vivanza Biosciences's average Accounts Receivable for the three months ended in Sep. 2024 was ₹134.0 Mil. Vivanza Biosciences's Revenue for the three months ended in Sep. 2024 was ₹30.0 Mil. Hence, Vivanza Biosciences's Days Sales Outstanding for the three months ended in Sep. 2024 was 407.43.

The historical rank and industry rank for Vivanza Biosciences's Days Sales Outstanding or its related term are showing as below:

BOM:530057' s Days Sales Outstanding Range Over the Past 10 Years
Min: 157.48   Med: 234.07   Max: 739.1
Current: 328.92

During the past 13 years, Vivanza Biosciences's highest Days Sales Outstanding was 739.10. The lowest was 157.48. And the median was 234.07.

BOM:530057's Days Sales Outstanding is ranked worse than
96.91% of 970 companies
in the Drug Manufacturers industry
Industry Median: 71.605 vs BOM:530057: 328.92

Vivanza Biosciences's Days Sales Outstanding increased from Sep. 2023 (233.03) to Sep. 2024 (407.43).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.


Vivanza Biosciences Days Sales Outstanding Historical Data

The historical data trend for Vivanza Biosciences's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vivanza Biosciences Days Sales Outstanding Chart

Vivanza Biosciences Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 232.09 236.05 247.27 208.25 157.48

Vivanza Biosciences Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 233.03 270.69 238.09 431.69 407.43

Competitive Comparison of Vivanza Biosciences's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Vivanza Biosciences's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vivanza Biosciences's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vivanza Biosciences's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Vivanza Biosciences's Days Sales Outstanding falls into.



Vivanza Biosciences Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Vivanza Biosciences's Days Sales Outstanding for the fiscal year that ended in Mar. 2024 is calculated as

Days Sales Outstanding (A: Mar. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Mar. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )*Days in Period
=( (124.794 + 115.394) / 2 ) / 278.35*365
=120.094 / 278.35*365
=157.48

Vivanza Biosciences's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

Days Sales Outstanding (Q: Sep. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2024 ) + Accounts Receivable (A: Sep. 2024 )) / count ) / Revenue (A: Sep. 2024 )*Days in Period
=( (0 + 133.976) / 1 ) / 30.006*365 / 4
=133.976 / 30.006*365 / 4
=407.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vivanza Biosciences  (BOM:530057) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Vivanza Biosciences Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Vivanza Biosciences's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Vivanza Biosciences Business Description

Traded in Other Exchanges
N/A
Address
S.G. Highway, 403/TF, Sarthik II, Opposite Rajpath Club, Bodakdev, Ahmedabad, GJ, IND, 380054
Vivanza Biosciences Ltd is a pharmaceutical company. Its core focus areas include research and development, manufacturing, and the distribution of a wide range of pharma and pharmaceutical products. The company's product portfolio includes Medical examination gloves, Injections, Veterinary feeds, and others.

Vivanza Biosciences Headlines

No Headlines